Early Detection of Anthracycline-Induced Cardiotoxicity in Breast Cancer Survivors With T2 Cardiac Magnetic Resonance
Maryam B. Lustberg(Yale Cancer Center), Charles L. Shapiro(Tisch Hospital), Philip F. Binkley(The Ohio State University Wexner Medical Center), Daniel Addison(The University of Texas Southwestern Medical Center), Bhuvaneswari Ramaswamy(The Ohio State University), Raquel E. Reinbolt(The Ohio State University), Sarah Carothers(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Anupama Suresh(The Ohio State University Wexner Medical Center), Subha V. Raman(OhioHealth), Michael Berger(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Sean Moore(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Hiranmoy Das(Texas Tech University), Amy S. Ruppert(The University of Texas MD Anderson Cancer Center), Robert Wesolowski(The Ohio State University Wexner Medical Center)
Cited by 32
Related Papers
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2014|1.2k
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update
|Journal of Clinical Oncology|2020|1.1k
Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline
|American Journal of Respiratory and Critical Care Medicine|2020|1k
The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019
|The Lancet|2022|955
Myocardial Viability and Survival in Ischemic Left Ventricular Dysfunction
|New England Journal of Medicine|2011|877